Basit öğe kaydını göster

Management of Hepatotoxicity Induced by the Use of Olanzapine

dc.contributor.authorSelimoglu, Ayse
dc.contributor.authorDonmez, Yunus Emre
dc.contributor.authorÖZCAN, ÖZLEM
dc.contributor.authorSOYLU, Nusret
dc.contributor.authorKARTAL SARIOĞLU, FATMA
dc.date.accessioned2022-02-18T10:01:07Z
dc.date.available2022-02-18T10:01:07Z
dc.date.issued2017
dc.identifier.citationDonmez Y. E. , ÖZCAN Ö., SOYLU N., KARTAL SARIOĞLU F., Selimoglu A., "Management of Hepatotoxicity Induced by the Use of Olanzapine", JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, cilt.27, sa.3, ss.293-294, 2017
dc.identifier.issn1044-5463
dc.identifier.othervv_1032021
dc.identifier.otherav_7457e1d6-47ad-4b5c-848c-f3ef8af268b8
dc.identifier.urihttp://hdl.handle.net/20.500.12627/178432
dc.identifier.urihttps://doi.org/10.1089/cap.2016.0178
dc.description.abstractNumerous drugs cause hepatotoxicity clinically or biologically. Neuropsychiatric drugs constitute 16% of these drugs. The occurrence of hepatotoxicity induced by the use of olanzapine is expressed by the researchers. In such cases, generally the dose of olanzapine is reduced or the drug is completely discontinued and the treatment of the patient fails. The aim of this study is to report the case for whom elevated liver enzymes were observed but the process was managed without changing treatment dose and drug and to discuss this case with literature information. The present study has characteristics of being the first in the literature concerning management of the process.
dc.language.isoeng
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectPediatrics
dc.subjectPsychiatric Mental Health
dc.subjectPharmacology (medical)
dc.subjectPsychiatry and Mental Health
dc.subjectPediatrics, Perinatology and Child Health
dc.subjectDrug Guides
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectPharmacy
dc.subjectPEDİATRİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectPsikiyatri
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectPharmacology
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.titleManagement of Hepatotoxicity Induced by the Use of Olanzapine
dc.typeMakale
dc.relation.journalJOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
dc.contributor.departmentİnönü Üniversitesi , ,
dc.identifier.volume27
dc.identifier.issue3
dc.identifier.startpage293
dc.identifier.endpage294
dc.contributor.firstauthorID3385348


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster